Regio‐selectively reduced streptogramin A analogue, 5,6‐dihydrovirginiamycin M1 exhibits improved potency against MRSA

A newly reduced macrocyclic lactone antibiotic streptogramin A, 5,6‐dihydrovirginiamycin M1 was created by feeding virginiamycin M1 into a culture of recombinant Streptomyces venezuelae. Its chemical structure was spectroscopically elucidated, and this streptogramin A analogue showed twofold higher...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Letters in applied microbiology Ročník 57; číslo 5; s. 393 - 398
Hlavní autori:	Hoang, N.H., Huong, N.L., Shrestha, A., Sohng, J.K., Yoon, Y.J., Park, J.W.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Oxford Blackwell 01.11.2013 Oxford University Press
Predmet:	Acetyltransferase Anti-Bacterial Agents - pharmacology Antimicrobial agents Biological and medical sciences Biosynthesis Biotransformation enhanced anti‐MRSA activity Fundamental and applied biological sciences. Psychology Methicillin-Resistant Staphylococcus aureus - drug effects microbial biocatalyst Microbiology reduced macrocyclic lactone Staphylococcus aureus Streptogramin A - analogs & derivatives Streptogramin A - biosynthesis Streptogramin A - chemistry Streptogramin A - pharmacology streptogramin A antibiotic Streptomyces venezuelae Virginiamycin - metabolism Streptomycetaceae reduced macrocyclic lactone Applied microbiology Streptomyces venezuelae Lactone Biocatalyst Macrocycle Actinomycetales Antibiotic streptogramin A antibiotic microbial biocatalyst Analog Bacteria Actinomycetes Microorganism enhanced anti-MRSA activity
ISSN:	0266-8254, 1472-765X, 1472-765X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!